Purpose of review The prevalence of heart failure with preserved ejection fraction (HFpEF) is
rising and in some places, it is already the most prevalent form of heart failure. The usual …

Heart failure with preserved ejection fraction (HFpEF) does not exist as a singular clinical or
pathological entity but as a syndrome encompassing a wide range of clinical and biological …

Heart failure with preserved ejection fraction (HFpEF) is increasingly prevalent and
represents more than half of all heart failure cases. It is defined by the presence of heart …

Heart failure with preserved ejection fraction (HFpEF) is an increasingly prevalent
phenotype affecting over half of today's heart failure patients. With no proven therapy and no …

Understanding of the pathophysiology of heart failure with preserved ejection fraction
(HFpEF) has advanced rapidly over the past two decades. Currently, HFpEF is recognized …

Heart failure with preserved ejection fraction (HFpEF) is a syndrome defined by the
presence of heart failure symptoms and increased levels of circulating natriuretic peptide …

Heart failure with preserved ejection fraction (HFpEF) is an important global health problem.
Despite increased prevalence due to improved diagnostic options, limited improvement has …

Background: Heart failure with preserved ejection fraction (HFpEF) is a multifactorial
condition with a variety of pathophysiological causes and morphological manifestations. The …

Heart failure with preserved ejection fraction (HFpEF) is a major healthcare problem that is
raising in prevalence. There has been a shift in HpEF management towards early diagnosis …

Heart failure with preserved ejection fraction (HFpEF) is highly prevalent, affecting
approximately half of all patients with heart failure. 1 It is a significantly heterogeneous …